References
- Weidmann E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 2000;14:991–7.
- Salhany KE, Feldman M, Kahn MJ, et al. Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation. Hum Pathol 1997;28:674–85.
- Macon WR, Lew NB, Kurtin PJ, et al. Hepatosplenic [alpha][beta] T-Cell Lymphomas: a report of 14 cases and comparison with hepatosplenic [gamma][delta] T-Cell Lymphomas. Am J Surg Pathol 2001;25:285–296.
- Kotlyar DS, Osterman MT, Diamond RH, et al. A systematic review of factors that contribute to hepatosplenic t-cell lymphoma in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2011;9:36–41.1.
- Knipp S, Hildebrandt B, Richter J, et al. Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7. Haematologica 2005;90:691–693.
- Lai R LL, Etches W, Mortimer ST, et al. Hepatosplenic T-cell lymphoma of [alpha][beta] lineage in a 16-year-old boy presenting with hemolytic anemia and thrombocytopenia. Am J Surg Pathol 2000;24:459–463.
- Chanan-Khan A, Islam T, Alam A, et al. Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with α/β hepatosplenic T-cell non-Hodgkin’s lymphoma. Leuk Lymphoma 2004;45:1673–1675.
- Mansour MR, Dogan A, Morris EC, et al. Allogeneic transplantation for hepatosplenic [alpha][beta] T-cell lymphoma. Bone Marrow Transplant 2005;35:931–934.
- Machino T, Okoshi Y, Kaneko S, et al. Hepatosplenic [alpha][beta] T-cell lymphoma successfully treated with allogeneic bone marrow transplantation. Bone Marrow Transplant 2007;39:513–514.
- Tse E, Kwong Y-L. Treatment algorithms for mature T-cell and natural killer-cell neoplasms. Future Oncol 2011;7:1101–1112.